Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients

被引：0
|
作者：
Ragne K. Farmen
Oddmund Nordgård
Bjørnar Gilje
Fuad V. Shammas
Jan T. Kvaløy
Satu Oltedal
Reino Heikkilä
机构：
[1] Stavanger University Hospital,Department of Hematology and Oncology
[2] University of Stavanger,Department of Mathematics and Natural Science
[3] Stavanger University Hospital,Division of Research and Human Resources
[4] Gena AS,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 108卷
关键词：
Breast cancer; Bone marrow; Micrometastases; Real-time RT-PCR; Cytokeratin 19; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 258
页数：7
相关论文
共 50 条
  • [21] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Hou, Ming-Feng
    Chen, Po-Ming
    Chu, Pei-Yi
    BMC CANCER, 2018, 18
  • [22] RELAPSE-FREE SURVIVAL IN BREAST-CANCER PATIENTS - THE IMPORTANCE OF THE PRESENCE OF PROGESTERONE RECEPTORS FOR PROGNOSIS
    ZIELINSKI, CC
    KUZMITS, R
    SPONA, J
    SALZER, H
    KUBISTA, E
    STAFFEN, A
    AIGINGER, P
    BLUT, 1984, 49 (03): : 243 - 243
  • [23] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Ming-Feng Hou
    Po-Ming Chen
    Pei-Yi Chu
    BMC Cancer, 18
  • [24] Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients
    Trilla-Fuertes, Lucia
    Gamez-Pozo, Angelo
    Diaz-Almiron, Mariana
    Prado-Vazquez, Guillermo
    Zapater-Moros, Andrea
    Lopez-Vacas, Rocio
    Nanni, Paolo
    Zamora, Pilar
    Espinosa, Enrique
    Fresno Vara, Juan Angel
    FUTURE ONCOLOGY, 2019, 15 (30) : 3483 - 3490
  • [25] Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
    Paul N Span
    Peggy Manders
    Joop J Heuvel
    Chris MG Thomas
    Remko R Bosch
    Louk VAM Beex
    CGJ (Fred) Sweep
    Oncogene, 2002, 21 : 8506 - 8509
  • [26] Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
    Span, PN
    Manders, P
    Heuvel, JJ
    Thomas, CMG
    Bosch, RR
    Beex, LV
    Sweep, CGJ
    ONCOGENE, 2002, 21 (55) : 8506 - 8509
  • [27] mTOR staining in bone marrow and spleen tissues of immune thrombocytopenia patients is associated with shorter relapse-free survival
    Pamuk, G. E.
    Puyan, Oz F.
    Uyanik, M. S.
    Tastekin, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 103 - 103
  • [28] Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients
    Kruger, W
    Krzizanowski, C
    Holweg, M
    Stockschlader, M
    Kroger, N
    Jung, R
    Mross, K
    Jonat, W
    Zander, AR
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (11) : 679 - 686
  • [29] Occupational risk factors for relapse-free survival in bladder cancer patients
    Selinski, Silvia
    Buerger, Hannah
    Blaszkewicz, Meinolf
    Otto, Thomas
    Volkert, Frank
    Moormann, Oliver
    Niedner, Hartmut
    Hengstler, Jan G.
    Golka, Klaus
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2016, 79 (22-23): : 1136 - 1143
  • [30] Worse event-free and relapse-free survival in financially disadvantaged patients with breast cancer in South India
    Thumsi, J.
    Nataraj, M.
    Kavitha, M. L.
    Jadhav, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S80 - S81
12345